Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Do the ends justify the means?

Nature Medicine volume 1, pages 203–205 (1995)Cite this article

Activation of the enzyme telomerase is associated with neuroblastoma and other cancers. Is it an effect or a cause of tumour formation (pages 249–255)?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Look, A.T., Hayes, F.A., Nitschke, R., McWilliams, N.B. & Green, A.A. Cellular DNA content as predictor of response to chemotherapy in infants with unresectable neuroblastoma. New Engl. J. Med. 311, 231–235 (1984).

    Article  CAS  Google Scholar 

  2. Franke, F., Rudolph, B., Christiansen, H., Har-bott, J. & Lampert, F. Tumour karyotype may be important in the prognosis of human neuroblastoma. J. Cancer Res. clin. Oncol. 111, 266–272 (1986).

    Article  CAS  Google Scholar 

  3. Kaneko, Y. et al. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res. 47, 311–318 (1987).

    CAS  PubMed  Google Scholar 

  4. Christiansen, H. & Lampert, F. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br. J. Cancer 57, 121–126 (1988).

    Article  CAS  Google Scholar 

  5. Hayashi, Y. et al. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 63, 126–132 (1989).

    Article  CAS  Google Scholar 

  6. Look, A.T. et al. Clinical relevance of tumour cell ploidy and N-myc gene amplification in childhood neuroblastoma. J. clin. Oncol, 9, 581–591 (1991).

    Article  CAS  Google Scholar 

  7. Brodeur, G.M., Sekhon, G.S. & Goldstein, M.N. Chromosomal aberrations in human neuroblastomas. Cancer 40, 2256–2263 (1977).

    Article  CAS  Google Scholar 

  8. Brodeur, G.M. et al. Cytogenetic features of human neuroblastomas and cell lines. Cancer Res. 41, 4678–4686 (1981).

    CAS  PubMed  Google Scholar 

  9. Fong, C.T. et al. Loss of heterozygosity for chromosome 1p in human neuroblastomas: Correlation with N-myc amplification. Proc. natn. Acad. Sci. U.S.A. 86, 3753–3757 (1989).

    Article  CAS  Google Scholar 

  10. Weith, A. et al. Neuroblastoma consensus deletion maps to lp36.1-2. Genes chrom. Cancer 1, 159–166 (1989).

    Article  CAS  Google Scholar 

  11. Brodeur, G.M., Seeger, R.C., Schwab, M., Varmus, H.E. & Bishop, J.M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224, 1121–1124 (1984).

    Article  CAS  Google Scholar 

  12. Seeger, R.C. et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. New Engl. J. Med. 313, 1111–1116 (1985).

    Article  CAS  Google Scholar 

  13. Brodeur, G.M., Clinical significance of genetic abnormalities. Cancer Surveys 9, 673–688 (1990).

    CAS  PubMed  Google Scholar 

  14. Nakagawara, A., Arima, M., Azar, C.G., Scavarda, N.J. & Brodeur, G.M. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res. 52, 1364–1368 (1992).

    CAS  PubMed  Google Scholar 

  15. Nakagawara, A. et al. Association between high levels of expression of the TRK gene and favourable outcome in human neuroblastoma. New Engl. J. Med. 328, 847–854 (1993).

    Article  CAS  Google Scholar 

  16. Kogner, P. et al. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favourable prognosis. Cancer Res. 53, 2044–2050 (1993).

    CAS  PubMed  Google Scholar 

  17. Suzuki, T., Bogenmann, E., Shimada, H., Stram, D. & Seeger, R.C. lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J natn. Cancer Inst. 85, 377–384 (1993).

    Article  CAS  Google Scholar 

  18. Borrello, M.G. et al. TRK and RET protooncogene expression in human neuroblastoma specimens: high-frequency of trk expression in non-advanced stages. Int J Cancer 54, 540–545 (1993).

    Article  CAS  Google Scholar 

  19. Kim, N.-W. et al. Specific association of human telomerase activity with immortal cCells and cancer. Science 266, 2011–2015 (1994).

    Article  CAS  Google Scholar 

  20. Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M.A. & Shay, J.W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med. 1, 249–255 (1995).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, USA

    Garrett M. Brodeur

Authors
  1. Garrett M. Brodeur
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brodeur, G. Do the ends justify the means?. Nat Med 1, 203–205 (1995). https://doi.org/10.1038/nm0395-203

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0395-203

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing